Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Research
Repair licenses Genevant's tech for up to $107M per product
Repair will use Genevant's lipid nanoparticle technology to create cholesterol-degrading treatments for atherosclerosis.
Darren Incorvaia
Sep 26, 2024 2:53pm
Acepodia, Pfizer click together for chemistry-based cell therapy
Sep 3, 2024 5:00pm
NovAliX, Bruker team up to build new drug discovery methods
Aug 8, 2024 3:49pm
Daiichi pays Merck $170M to form lung cancer T-cell engager pact
Aug 6, 2024 8:17am
Autobahn Labs accelerates with Charles River partnership
Jul 24, 2024 2:14pm
Boehringer Ingelheim to surf with Melbourne biotech
May 5, 2023 10:58am
